MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma

This publication has 9 references indexed in Scilit:

• MIB-1 Proliferative Activity Is a Significant Prognostic Factor in Primary Thick Cutaneous Melanomas
  Journal of Investigative Dermatology, 1995
• Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki‐67 monoclonal antibodies in melanocytic skin lesions
  Journal of Cutaneous Pathology, 1993
• Effects of systemic interferon-α (IFN-α) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852
  Melanoma Research, 1993
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections
  The Journal of Pathology, 1992
• The Ki-67 antigen in primary human melanomas ?its relationship to mitotic rate and tumor thickness and its stability
  Archives of Dermatological Research, 1989
• Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival
  Radiotherapy and Oncology, 1989
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
  The Journal of Immunology, 1984
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma
  Annals of Surgery, 1970